Clin2
NCT07525219Likely a fitRecruiting

Pain Relief During Stereotactic Head Frame Placement

Analgesic Efficacy

Treatments studied

Part of Pain clinical trials.

This study compares a new pain medication called suzetrigine with acetaminophen (Tylenol) for patients who need a stereotactic head frame placed as part of their scheduled medical procedure. The frame holds your head still during brain imaging or treatment.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
80 people
Ages
21 years and older
Study type
Interventional

Who can take part

  • You must have a scheduled medical procedure that requires placing a stereotactic head frame
  • The procedure must be a standard of care treatment (not experimental)
  • You must be willing to receive either suzetrigine or acetaminophen for pain management
  • You must be able to participate in the study during your procedure

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07463430Enrolling by invitation· Phase 4
Suzetrigine for pain after non-mastectomy breast surgery

This trial tests a new pain medication, suzetrigine, for people having breast surgery (not mastectomy) who are expected to have moderate pain. It checks if this drug works well compared to standard options.

San Diego, California
NCT07539623Recruiting· Phase 3
Pain relief with suzetrigine after heart or weight-loss surgery

This study tests whether suzetrigine, a new pain medication, can reduce the need for opioids (strong painkillers) after cardiac or bariatric surgery. The goal is to help patients manage pain with fewer opioid-related side effects.

New York, New York
NCT07796152Not yet recruiting· Phase 4
Comparing pain relief options after knee replacement

This study compares two pain relief approaches after knee replacement surgery to see which works better. If you qualify, you will receive either the study medication or standard care to manage your pain.

Skokie, Illinois
NCT07624526Not yet recruiting· Phase 4
Non-opioid pain reliever after knee replacement surgery

This study tests a new non-opioid pain reliever (suzetrigine) combined with other standard treatments to control pain after knee replacement surgery, with the goal of reducing opioid use. If effective, it could offer better pain control with fewer opioid-related risks.

Atlanta, Georgia
NCT07654296Not yet recruiting· Phase 3
Suzetrigine for pain relief after ureteroscopy

This trial tests a new non-opioid pain medication called suzetrigine to see if it can help reduce pain after ureteroscopy, a procedure often used to treat kidney stones. If you're having this procedure, the study may help you manage pain with fewer side effects than opioids.

Boston, Massachusetts
NCT07548385Recruiting· Phase 3
New pain medicine for after knee replacement surgery

This study tests a new medication called suzetrigine to help manage pain after knee replacement surgery. The goal is to see if it reduces pain and discomfort better than current treatments.

New York, New York

Hear when a new Analgesic Efficacy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.